Results 321 to 330 of about 98,296 (378)

Severe Systemic Arthralgia After Zoledronic Acid Infusion in a Patient With Thyroid Dysfunction and Osteoporosis. [PDF]

Cureus
Kpughur-Tule MP, Hubers CM, Conway K, Reguram R, Satei AM, Yerasuri D.   +5 more
europepmc   +1 more source

Prevalence of Osteonecrosis of the Jaw Following Tooth Extraction in Patients with Osteoporosis: A Systematic Review and Meta-Analysis. [PDF]

J Clin Med
Kostares E, Kostare G, Kostares M, Pitsigavdaki F, Perisanidis C, Kantzanou M.   +5 more
europepmc   +1 more source

Patterns of adjuvant bone modifying agent use in patients with early-stage breast cancer in the United States. [PDF]

Breast Cancer Res
Odzer N, Chehayeb RJ, Schellhorn SE, Lustberg M, Gross CP, Lee D, Foldi J.   +6 more
europepmc   +1 more source

Influence of Tempeh, Daidzein, Probiotics, and Their Combination on Magnesium Status and Hematological Ratios in a Postmenopausal Osteoporotic Animal Model. [PDF]

Nutrients
Harahap IA, Salem O, Fahmi RL, Ahmed N, Leciejewska N, Suliburska J.   +5 more
europepmc   +1 more source

Bisphosphonate-Related Osteonecrosis of the Jaw: A 10-Year Analysis of Risk Factors and Clinical Outcomes. [PDF]

J Clin Med
Stelea CG, Bologa E, Boișteanu O, Platon AL, Stelea ȘO, Gelețu GL, Onică CA, Șulea D, Ciofu ML, Costan VV.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Bisphosphonates

Annals of the New York Academy of Sciences, 2006
Abstract:  Bisphosphonates belong to a class of compounds similar to pyrophosphate. In these compounds the oxygen atom of the pyrophosphate is replaced by a carbon atom resulting in a P‐C‐P bond. They exert a potent inhibitory effect on osteoclasts and are therefore potent antiresorptive agents. They reduce bone turnover, increase bone mineral density,
Irene, Lambrinoudaki, George, Christodoulakos, Dimitrios, Botsis   +2 more
openaire   +3 more sources

Bisphosphonates and Bisphosphonate Induced Osteonecrosis

Oral and Maxillofacial Surgery Clinics of North America, 2007
Bisphosphonate-induced osteonecrosis of the jaws is the correct term for this real drug complication that most dental practitioners face. All nitrogen-containing bisphosphonates pose a risk, which is related to the route of administration, the potency of the bisphosphonate, and the duration of use.
Yoh Sawatari, Robert E. Marx
openaire   +2 more sources

Bisphosphonate and Teriparatide Use in Thoracolumbar Spinal Fusion: A Systematic Review and Meta-analysis of Comparative Studies

Spine, 2018
Study Design. Systematic review and meta-analysis. Objective. To compare the efficacy of the use of either bisphosphonates or teriparatide on radiographic and functional outcomes of patients that had thoracolumbar spinal fusion.
Rafael A. Buerba, Akshay Sharma, Chason Ziino, Alexander H Arzeno, Remi M. Ajiboye   +4 more
semanticscholar   +1 more source

Pharmacology of bisphosphonates

Bone, 2011
Four decades of preclinical and clinical research of the pharmacology of bisphosphonates have generated data and concepts that have considerably improved their clinical use. However, despite this progress several pharmacological aspects relevant to bisphosphonate action on bone are still incompletely understood.
Cremers, S., Papapoulos, S.
openaire   +4 more sources